Attached files
file | filename |
---|---|
10-K/A - AMENDMENT NO. 2 TO FORM 10-K - Jazz Pharmaceuticals plc | d10ka.htm |
EX-31.5 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plc | dex315.htm |
EXHIBIT 31.6
CERTIFICATION
I, Kathryn E. Falberg, certify that:
1. | I have reviewed this Amendment No. 2 to the annual report on Form 10-K/A of Jazz Pharmaceuticals, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: December 11, 2009 | By: | /S/ KATHRYN E. FALBERG | ||||
Kathryn E. Falberg | ||||||
Chief Financial Officer |